Position in BLLN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,052
New position
Shares Held
64
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026US BANCORP \DE\ holds $252,886,550 across 31 Diagnostics & Research names. BLLN ranks #28 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DHR |
Danaher Corp /De/
|
598,192 | $113,417,201 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
166,108 | $81,647,064 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
15,200 | $8,540,726 | |
| 4 | A |
Agilent Technologies, Inc.
|
53,749 | $6,126,309 | |
| 5 | IQV |
Iqvia Holdings Inc.
|
31,459 | $5,365,016 | |
| 6 | LH |
Labcorp Holdings Inc.
|
19,877 | $5,303,380 | |
| 7 | ILMN |
Illumina, Inc.
|
35,531 | $4,379,550 | |
| 8 | DGX |
Quest Diagnostics Inc
|
20,905 | $4,096,960 |
All Filings in BLLN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,052 | 64 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||